BioSig Technologies, Current Valuation vs. Number Of Shares Shorted
| BSGM Stock | USD 1.79 0.12 6.28% |
For BioSig Technologies, profitability analysis, we use financial ratios and fundamental drivers that measure the ability of BioSig Technologies, to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well BioSig Technologies, Common utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between BioSig Technologies,'s most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of BioSig Technologies, Common over time as well as its relative position and ranking within its peers.
BioSig |
BioSig Technologies, Number Of Shares Shorted vs. Current Valuation Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining BioSig Technologies,'s current stock value. Our valuation model uses many indicators to compare BioSig Technologies, value to that of its competitors to determine the firm's financial worth. BioSig Technologies, Common is rated below average in current valuation category among its peers. It is rated below average in number of shares shorted category among its peers making about 0.07 of Number Of Shares Shorted per Current Valuation. The ratio of Current Valuation to Number Of Shares Shorted for BioSig Technologies, Common is roughly 13.94 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the BioSig Technologies,'s earnings, one of the primary drivers of an investment's value.BioSig Current Valuation vs. Competition
BioSig Technologies, Common is rated below average in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is currently estimated at about 2.51 Billion. BioSig Technologies, adds roughly 6.43 Million in current valuation claiming only tiny portion of equities under Health Care industry.
BioSig Number Of Shares Shorted vs. Current Valuation
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
BioSig Technologies, |
| = | 6.43 M |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
BioSig Technologies, |
| = | 461.7 K |
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.
BioSig Number Of Shares Shorted Comparison
BioSig Technologies, is currently under evaluation in number of shares shorted category among its peers.
BioSig Technologies, Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in BioSig Technologies,, profitability is also one of the essential criteria for including it into their portfolios because, without profit, BioSig Technologies, will eventually generate negative long term returns. The profitability progress is the general direction of BioSig Technologies,'s change in net profit over the period of time. It can combine multiple indicators of BioSig Technologies,, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut. Biosig Technologies operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 50 people.
BioSig Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on BioSig Technologies,. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of BioSig Technologies, position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the BioSig Technologies,'s important profitability drivers and their relationship over time.
Use BioSig Technologies, in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if BioSig Technologies, position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioSig Technologies, will appreciate offsetting losses from the drop in the long position's value.BioSig Technologies, Pair Trading
BioSig Technologies, Common Pair Trading Analysis
The ability to find closely correlated positions to BioSig Technologies, could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace BioSig Technologies, when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back BioSig Technologies, - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling BioSig Technologies, Common to buy it.
The correlation of BioSig Technologies, is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as BioSig Technologies, moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if BioSig Technologies, moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for BioSig Technologies, can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your BioSig Technologies, position
In addition to having BioSig Technologies, in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Broad Equity ETFs Thematic Idea Now
Broad Equity ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Broad Equity ETFs theme has 483 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Broad Equity ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in BioSig OTC Stock
To fully project BioSig Technologies,'s future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of BioSig Technologies, at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include BioSig Technologies,'s income statement, its balance sheet, and the statement of cash flows.